lopinavir has been researched along with Acquired Immune Deficiency Syndrome in 54 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.85) | 18.2507 |
| 2000's | 32 (59.26) | 29.6817 |
| 2010's | 17 (31.48) | 24.3611 |
| 2020's | 4 (7.41) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YC; Dumond, JB; Fiscus, SA; Horton, AL; Kashuba, AD; Patterson, KB; Rezk, NL; Tappouni, HL; Tien, HC; Vourvahis, M; Yeh, RF | 1 |
| Akpomiemie, G; Christofides, N; Lalla-Edward, S; Machisa, M; Mokgethi, NO | 1 |
| Chen, Y; Fu, G; Huang, X; Li, L; Li, Q; Li, Y; Ma, P; Qiao, Y; Su, B; Wang, H; Wang, L; Wang, R; Wu, G; Wu, X; Xin, X; Xu, J; Yang, Y; Zhang, T; Zou, H | 1 |
| Amaro, C; Azurara, L; Miroux-Catarino, A; Monteiro, AF; Silva, L; Viana, I | 1 |
| Cai, J; Lang, G; Ni, Q; Shen, X; Sheng, J; Su, J; Wu, W; Xu, K; Zhao, H; Zhu, B | 1 |
| Ayers, D; Calmy, A; Chan, K; Cooper, DA; Doherty, M; Ford, N; Kanters, S; Mills, EJ; Nsanzimana, S; Paton, NI; Popoff, E; Socias, ME; Vitoria, M; Wiens, MO | 1 |
| Chimukangara, B; Katzenstein, D; Manasa, J; Masimirembwa, C; Mitchell, R; Nyabadza, G | 1 |
| Abgrall, S; Arribas, JR; Barger, D; Barrufet, P; Braun, D; Caniglia, EC; Cardoso, SW; Chrysos, G; Costagliola, D; Gill, J; Gogos, C; Hauser, C; Hernán, MA; Hoyos, SP; Justice, A; Leyes, M; Lodi, S; Logan, R; Meyer, L; Moreno, S; Muga, R; Pacheco, A; Phillips, A; Porter, K; Reiss, P; Sabin, CA; Seng, R; Tate, J; van Sighem, A; Vandenhende, MA; Winston, A | 1 |
| Anderson, AM; Coffie, PA; Dabis, F; Eholie, SP; Ekouevi, DK; Gottlieb, GS; Tchounga, BK; Tegbe, J; Vitoria, M | 1 |
| Arnedo, M; Domingo, P; Egaña-Gorroño, L; Escribà, T; Fontdevila, J; Gatell, JM; Loncà, M; Martínez, E; Negredo, E; Vidal, F | 1 |
| Aga, E; Badal-Faesen, S; Bartlett, JA; Crump, JA; Hosseinipour, MC; Katzenstein, DA; Klingman, KL; Kumarasamy, N; Norton, MR; Ribaudo, HJ; Stevens, WS; Supparatpinyo, K; Wallis, CL | 1 |
| Hu, Z; Li, Z; Wei, H; Yang, Y | 1 |
| Amani Bosse, C; Amorissani Folquet, M; Avit, D; Ciaranello, A; Dainguy, E; Desmonde, S; Eboua, FT; Leroy, V; Mea, V; Ngbeché, S; Petit, J; Timite-Konan, M | 1 |
| Arribas, JR; Bellos, NC; Bernstein, BM; Brun, SC; Cameron, DW; da Silva, BA; Gilmore, N; Hanna, GJ; King, MS; Myers, RA | 1 |
| Avihingsanon, A; Bredeek, UF; Brunetta, J; Guittari, CJ; Jayaweera, D; Larson, P; Raffi, F; Ruxrungtham, K; Schutz, M; Slim, J; Walmsley, S; Ward, DJ | 1 |
| Angarano, G; Monno, L; Saracino, A; Tartaglia, A; Tinelli, C | 1 |
| Covington, DL; Martinez, M; Pasley, MV; Roberts, SS; Rode, RA; Woodward, WC | 1 |
| Chandrasekar, S; Jayakanthan, M; Mathur, PP; Muthukumaran, J | 1 |
| Dhlomo, S; Emery, S; Grandits, G; Khabo, P; Khanyile, T; Komati, S; Magongoa, D; Naidoo, LC; Neaton, JD; Polis, M; Qolohle, D; Ratsela, A | 1 |
| Burgos, J; Crespo, M; Curran, A; del Rio, L; Domingo, P; Gatell, JM; Larrousse, M; Lonca, M; Martinez, E; Podzamczer, D; Ribera, E; Saumoy, M | 1 |
| Del Rio, C; Easley, KA; Eaton, ME; Lennox, JL; Ofotokun, I; Sanford, SE; Shenvi, N; Sheth, AN; White, K | 1 |
| Butcher, D; Farajallah, A; Hu, W; Juethner, S; McDonald, C; McGrath, D; Moyle, G; Uy, J; Wirtz, V | 1 |
| Aga, E; Badal-Faesen, S; Bartlett, JA; Crump, JA; Hosseinipour, MC; Kallungal, BA; Katzenstein, DA; Klingman, KL; Kumarasamy, N; Norton, MR; Ribaudo, HJ; Stevens, WS; Supparatpinyo, K; Wallis, CL | 1 |
| Azzoni, L; Ertl, HC; Firnhaber, C; Foulkes, AS; Gross, R; Li, Y; Montaner, LJ; Sanne, I; Stevens, W; Xiang, ZQ; Yin, X | 1 |
| Capeau, J; Danner, SA; Domingo, P; Feeney, ER; Mallon, PW; Reiss, P; van Agtmael, MA; van Vonderen, MG; Villarroya, F; Wit, F | 1 |
| Ambrosioni, J; Calmy, A; Daou, S; Merkler, D | 1 |
| Genka, I; Ishizaki, A; Kikuchi, Y; Oka, S; Sunagawa, K; Yasuoka, A | 1 |
| Bacconier, J; Basso, S; Durand, A; Lacarelle, B; Poizot-Martin, I; Quinson, AM; Ravaux, I; Solas, C | 1 |
| Jiménez, FJ; Labarga, P; Pinilla, J; Repiso, M | 1 |
| Abad, S; Blanche, P; Chauvelot-Moachon, L; Daniel, N; Kélaïdi, C; Nazal, EM; Rollot, F; Saba, M | 1 |
| Bellón, JM; Cabrero, E; de José, MI; González, MI; Gonzalez-Rivera, M; Gurbindo, D; Mellado, MJ; Muñoz-Fernández, MA; Ramos, JT; Resino, S | 1 |
| Susman, E | 1 |
| Bergshoeff, AS; Burger, DM; De Groot, R; Fraaij, PL; Hartwig, NG; Ndagijimana, J; Niehues, T; Verweel, G | 1 |
| Kitano, K; Saito, H; Yotsumoto, M | 1 |
| Nau, JY | 1 |
| Chinegwundoh, F; Ghani, KR | 1 |
| Boyle, BA; Cohen, CJ; Elion, R; Frank, I; Moyle, GJ; Sax, PE | 1 |
| Bainbridge, A; Jäger, HR; Miller, RF; Usiskin, SI | 1 |
| Chadwick, EG; Chen, J; Gaur, AH; Havens, P; Hughes, M; Palumbo, P; Persaud, D; Purswani, M; Ray, SC; Ziemniak, C | 1 |
| Brown, JD; Kangwanprasert, M; Melish, J; Tice, A | 1 |
| Almeida, F; Angelis, DS; Beltrão, SV; Bononi, F; Cardoso, MR; Cavalheiro, K; Cunegundes, KS; Gouvêa, Ade F; Machado, DM; Succi, RC | 1 |
| Antinori, A; Baxter, J; Cauda, R; Clevenbergh, P; Colafigli, M; De Luca, A; Giambenedetto, SD; Perno, CF; Prosperi, M; Ruiz, L; Trotta, MP | 1 |
| Buckley, NA; Ray, JE; Roberts, DM | 1 |
| Galegov, GA | 1 |
| Agosto, M | 1 |
4 review(s) available for lopinavir and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Comparative efficacy and safety of second-line antiretroviral therapy for treatment of HIV/AIDS: a systematic review and network meta-analysis.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Anti-HIV Agents; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lopinavir; Male; Network Meta-Analysis; Prospective Studies; Raltegravir Potassium; Retrospective Studies; Reverse Transcriptase Inhibitors; Ritonavir | 2017 |
Antiretroviral therapy response among HIV-2 infected patients: a systematic review.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Female; HIV Infections; HIV-2; Humans; Indinavir; Lopinavir; Male; Middle Aged; Nelfinavir; Ritonavir; Treatment Outcome | 2014 |
Intracranial hypertension following highly active antiretroviral therapy interruption in an HIV-infected woman: case report and review of the literature.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Darunavir; Decompressive Craniectomy; Dideoxynucleosides; Female; Humans; Intracranial Hypertension; Lopinavir; Medication Adherence; Meningoencephalitis; Organophosphonates; Sulfonamides; Tenofovir; Treatment Outcome | 2013 |
[Complete auriculoventricular block in a patient treatment with Lopinavir/Ritonavir].
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Aryl Hydrocarbon Hydroxylases; Bundle-Branch Block; Cytochrome P-450 CYP3A; Drug Interactions; Enzyme Inhibitors; Heart; Heart Block; HIV Protease Inhibitors; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Oxidoreductases, N-Demethylating; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Syncope; Zidovudine | 2002 |
13 trial(s) available for lopinavir and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Differential subcutaneous adipose tissue gene expression patterns in a randomized clinical trial of efavirenz or lopinavir-ritonavir in antiretroviral-naive patients.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adipogenesis; Adiponectin; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Body Composition; CCAAT-Enhancer-Binding Proteins; Cyclopropanes; Deoxycytidine; Drug Combinations; Emtricitabine; Energy Metabolism; Female; Gene Expression; Glucose; Glucose Transporter Type 4; HIV-1; Humans; Inflammation; Lipid Metabolism; Lipoprotein Lipase; Lopinavir; Male; Organophosphonates; Reverse Transcriptase Inhibitors; Ritonavir; Subcutaneous Fat; Tenofovir | 2014 |
Costs of Care of HIV-Infected Children Initiating Lopinavir/Ritonavir-Based Antiretroviral Therapy before the Age of Two in Cote d'Ivoire.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Cote d'Ivoire; Female; Follow-Up Studies; Health Care Costs; HIV Infections; Humans; Infant; Lopinavir; Lost to Follow-Up; Male; Outcome Assessment, Health Care; Prospective Studies; Ritonavir; Survival Rate | 2016 |
A 96-week comparison of lopinavir-ritonavir combination therapy followed by lopinavir-ritonavir monotherapy versus efavirenz combination therapy.
Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Diarrhea; Drug Therapy, Combination; Glucose Tolerance Test; HIV Protease Inhibitors; Humans; Lopinavir; Nausea; Pyrimidinones; Ritonavir; RNA, Viral; Time Factors; Treatment Outcome; Viral Load | 2008 |
Gemini: a noninferiority study of saquinavir/ritonavir versus lopinavir/ritonavir as initial HIV-1 therapy in adults.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV-1; Humans; Lipids; Lopinavir; Male; Middle Aged; Pyrimidinones; Ritonavir; RNA, Viral; Saquinavir | 2009 |
A randomized factorial trial comparing 4 treatment regimens in treatment-naive HIV-infected persons with AIDS and/or a CD4 cell count <200 cells/μL in South Africa.
Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Didanosine; Drug Therapy, Combination; Female; HIV; Humans; Lamivudine; Lopinavir; Male; Pyrimidinones; Ritonavir; RNA, Viral; South Africa; Stavudine; Treatment Outcome; Zidovudine | 2010 |
Body composition changes after switching from protease inhibitors to raltegravir: SPIRAL-LIP substudy.
Topics: Absorptiometry, Photon; Acquired Immunodeficiency Syndrome; Adipose Tissue; Adult; Anti-HIV Agents; Body Composition; Body Fat Distribution; Bone Density; Female; Femur Neck; HIV Protease Inhibitors; Humans; Lopinavir; Male; Middle Aged; Prospective Studies; Pyrrolidinones; Raltegravir Potassium; Ritonavir; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
A switch in therapy to a reverse transcriptase inhibitor sparing combination of lopinavir/ritonavir and raltegravir in virologically suppressed HIV-infected patients: a pilot randomized trial to assess efficacy and safety profile: the KITE study.
Topics: Acquired Immunodeficiency Syndrome; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Protease Inhibitors; HIV-1; Humans; Lipids; Lopinavir; Male; Middle Aged; Pilot Projects; Prospective Studies; Pyrrolidinones; Raltegravir Potassium; Ritonavir; RNA, Viral; Treatment Outcome; Viral Load | 2012 |
Clinical significance of hyperbilirubinemia among HIV-1-infected patients treated with atazanavir/ritonavir through 96 weeks in the CASTLE study.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Atazanavir Sulfate; Female; HIV-1; Humans; Hyperbilirubinemia; Lopinavir; Male; Medication Adherence; Oligopeptides; Pyridines; Quality of Life; Ritonavir; Surveys and Questionnaires | 2012 |
Antiretroviral therapy interruptions result in loss of protective humoral immunity to neoantigens in HIV-infected individuals.
Topics: Acquired Immunodeficiency Syndrome; Adult; Africa South of the Sahara; Anti-HIV Agents; Antibodies, Neutralizing; Antigens, Viral; Autoantigens; CD4-Positive T-Lymphocytes; Drug Administration Schedule; Female; HIV-1; Humans; Immunity, Humoral; Lopinavir; Lymphocyte Activation; Male; Ritonavir; Stavudine; Viral Load | 2012 |
Zidovudine/lamivudine but not nevirapine in combination with lopinavir/ritonavir decreases subcutaneous adipose tissue mitochondrial DNA.
Topics: Absorptiometry, Photon; Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Anti-HIV Agents; Atrophy; CD4 Lymphocyte Count; DNA, Mitochondrial; Drug Combinations; Drug Therapy, Combination; HIV Seropositivity; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Nevirapine; Prospective Studies; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Subcutaneous Fat; Treatment Outcome; Young Adult; Zidovudine | 2012 |
Increased dose of lopinavir/ritonavir compensates for efavirenz-induced drug-drug interaction in HIV-1-infected children.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Alkynes; Anti-HIV Agents; Area Under Curve; Benzoxazines; Child; Child, Preschool; Cyclopropanes; Drug Interactions; Drug Therapy, Combination; Female; HIV Protease Inhibitors; Humans; Lopinavir; Male; Oxazines; Pyrimidinones; Ritonavir; Safety | 2005 |
Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; DNA, Complementary; Drug Resistance, Viral; HIV-1; Humans; Infant; Lopinavir; Male; Pyrimidinones; Reverse Transcriptase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Ritonavir; RNA, Viral; United States; Viral Load; Zidovudine | 2007 |
Clinical data released on ABT-378/r.
Topics: Acquired Immunodeficiency Syndrome; Drug Combinations; HIV Protease Inhibitors; Humans; Lopinavir; Pyrimidinones; Ritonavir | 2000 |
37 other study(ies) available for lopinavir and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Genital tract, cord blood, and amniotic fluid exposures of seven antiretroviral drugs during and after pregnancy in human immunodeficiency virus type 1-infected women.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amniotic Fluid; Anti-HIV Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Female; Fetal Blood; Genitalia, Female; HIV-1; Humans; Hydrocortisone; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral | 2009 |
Quality of life and associated factors among people receiving second-line anti-retroviral therapy in Johannesburg, South Africa.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Darunavir; Female; HIV Infections; HIV-1; Humans; Lopinavir; Quality of Life; Ritonavir; South Africa | 2022 |
Associations of modern initial antiretroviral therapy regimens with all-cause mortality in people living with HIV in resource-limited settings: a retrospective multicenter cohort study in China.
Topics: Acquired Immunodeficiency Syndrome; Benzoxazines; China; Cohort Studies; Humans; Lopinavir; Nevirapine; Retrospective Studies | 2023 |
Pediatric Kaposi's sarcoma associated with immune reconstitution inflammatory syndrome.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Child; Dideoxynucleosides; Drug Therapy, Combination; Female; Humans; Immune Reconstitution Inflammatory Syndrome; Lamivudine; Lopinavir; Ritonavir; Sarcoma, Kaposi | 2020 |
Infection of severe acute respiratory syndrome coronavirus 2 in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Indoles; Interferon-alpha; Lopinavir; Lung; Male; Pandemics; Pneumonia, Viral; Radiography, Thoracic; Ritonavir; SARS-CoV-2; Sputum; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Community Based Antiretroviral Treatment in Rural Zimbabwe.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Child; Child, Preschool; Community Health Centers; Cross-Sectional Studies; Didanosine; Dideoxynucleosides; Drug Resistance, Viral; Female; HIV-1; Humans; Lopinavir; Male; Middle Aged; Nevirapine; Ritonavir; Rural Population; Treatment Failure; Viral Load; Young Adult; Zimbabwe | 2017 |
Commonly Prescribed Antiretroviral Therapy Regimens and Incidence of AIDS-Defining Neurological Conditions.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS Dementia Complex; AIDS-Related Opportunistic Infections; Alkynes; Americas; Atazanavir Sulfate; Benzoxazines; Cohort Studies; Cyclopropanes; Darunavir; Europe; Female; HIV Protease Inhibitors; Humans; Leukoencephalopathy, Progressive Multifocal; Lopinavir; Male; Meningitis, Cryptococcal; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Toxoplasmosis | 2018 |
Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230.
Topics: Acquired Immunodeficiency Syndrome; Adult; Africa; Antiviral Agents; Asia; Developing Countries; Drug Therapy; Female; HIV-1; Humans; Lopinavir; Male; Middle Aged; Pilot Projects; Plasma; Ritonavir; RNA, Viral; Treatment Outcome; Viral Load; Young Adult | 2015 |
Second-line Antiretroviral Treatment in Resource-Limited Settings: Abandon Lopinavir/Ritonavir Monotherapy or Search for New Candidates?
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Female; Humans; Lopinavir; Male; Ritonavir | 2015 |
[Preserving future therapy options. Darunavir--the protease inhibitor for various patient groups].
Topics: Acquired Immunodeficiency Syndrome; CD4 Lymphocyte Count; Clinical Trials as Topic; Darunavir; Drug Resistance, Multiple; Drug Resistance, Viral; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lopinavir; Pyrimidinones; Sulfonamides; Viral Load | 2008 |
Both a protective and a deleterious role for the L76V mutation.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Darunavir; Drug Resistance, Multiple, Viral; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Lopinavir; Mutation; Pyridines; Pyrimidinones; Pyrones; Sulfonamides | 2009 |
Lopinavir/ritonavir in pregnancy.
Topics: Abnormalities, Drug-Induced; Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Female; Humans; Lopinavir; Pregnancy; Pregnancy Complications, Infectious; Pyrimidinones; Registries; Ritonavir | 2009 |
Analysis of CYP3A4-HIV-1 protease drugs interactions by computational methods for Highly Active Antiretroviral Therapy in HIV/AIDS.
Topics: Acquired Immunodeficiency Syndrome; Antiretroviral Therapy, Highly Active; Computational Biology; Cytochrome P-450 CYP3A; Darunavir; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lopinavir; Nelfinavir; Pyridines; Pyrimidinones; Pyrones; Ritonavir; Sulfonamides | 2010 |
Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Africa; Anti-HIV Agents; Deoxycytidine; Drug Administration Schedule; Drug Therapy, Combination; Emtricitabine; Female; Health Resources; Humans; India; Lopinavir; Male; Medication Adherence; Middle Aged; Mutation; Organophosphonates; Patient Selection; Pilot Projects; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Surveys and Questionnaires; Tenofovir; Thailand; Treatment Failure; Viral Load | 2012 |
Serious bradyarrhythmia that was possibly induced by lopinavir-ritonavir in 2 patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Bradycardia; Humans; Lopinavir; Male; Middle Aged; Pyrimidinones; Ritonavir | 2002 |
Pharmacokinetic interaction between lopinavir/r and amprenavir in salvage therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Carbamates; Drug Interactions; Female; Furans; HIV-1; Humans; Lopinavir; Male; Middle Aged; Pyrimidinones; Retrospective Studies; Salvage Therapy; Sulfonamides | 2002 |
Tenofovir-related Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome: the role of lopinavir-ritonavir-didanosine.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Anti-HIV Agents; Diabetes Insipidus, Nephrogenic; Didanosine; Drug Therapy, Combination; Fanconi Syndrome; Humans; Lopinavir; Male; Organophosphonates; Organophosphorus Compounds; Pyrimidinones; Ritonavir; Tenofovir | 2003 |
[Justified hope after 4 years. Initial therapy still without resistance].
Topics: Acquired Immunodeficiency Syndrome; Clinical Trials, Phase II as Topic; Drug Combinations; Drug Resistance, Viral; Follow-Up Studies; HIV Protease Inhibitors; HIV-1; Humans; Long-Term Care; Lopinavir; Pyrimidinones; Ritonavir | 2003 |
[Results of a large randomized study: after switch to LPV/r quality of life improved].
Topics: Acquired Immunodeficiency Syndrome; Drug Combinations; HIV Protease Inhibitors; Humans; Lopinavir; Pyrimidinones; Quality of Life; Randomized Controlled Trials as Topic; Ritonavir | 2003 |
["Double boosting" passes the test. LPV/r plus SQV in complicated salvage situation].
Topics: Acquired Immunodeficiency Syndrome; Clinical Trials as Topic; Cohort Studies; Drug Resistance, Multiple, Viral; Drug Synergism; Germany; HIV Protease Inhibitors; Humans; Lopinavir; Pyrimidinones; Ritonavir; Salvage Therapy; Saquinavir | 2003 |
Positive virological outcome after lopinavir/ritonavir salvage therapy in protease inhibitor-experienced HIV-1-infected children: a prospective cohort study.
Topics: Acquired Immunodeficiency Syndrome; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cohort Studies; Drug Therapy, Combination; HIV-1; Humans; Lopinavir; Prospective Studies; Pyrimidinones; Ritonavir; Salvage Therapy | 2004 |
International AIDS Conference: compliance issues.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Clinical Trials as Topic; HIV Protease Inhibitors; Humans; Lopinavir; Patient Compliance; Pyrimidinones; Saquinavir; Treatment Outcome | 2004 |
Lopinavir monotherapy effective.
Topics: Acquired Immunodeficiency Syndrome; Clinical Trials as Topic; Drug Administration Schedule; HIV Protease Inhibitors; Humans; Lopinavir; Pyrimidinones; Treatment Outcome | 2004 |
Bradycardia-tachycardia syndrome induced by lopinavir-ritonavir in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Bradycardia; Drug Combinations; Dyspnea; Electrocardiography; Female; HIV Protease Inhibitors; Humans; Lopinavir; Middle Aged; Pyrimidinones; Ritonavir; Syndrome; Tachycardia | 2005 |
[When Doctors Without Borders writes to Miles White, chairman of Abbott Laboratories].
Topics: Acquired Immunodeficiency Syndrome; Developing Countries; Drug Combinations; Drug Industry; HIV Protease Inhibitors; Humans; International Agencies; Lopinavir; Pyrimidinones; Ritonavir | 2006 |
The urological management of the patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Lopinavir; Pyrimidinones; Ritonavir; Urologic Diseases | 2006 |
XVI International AIDS Conference: Part 2.
Topics: Acquired Immunodeficiency Syndrome; CCR5 Receptor Antagonists; Clinical Trials as Topic; Darunavir; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Organic Chemicals; Pyrimidinones; Pyrrolidinones; Raltegravir Potassium; Receptors, CCR5; Ritonavir; Salvage Therapy; Sulfonamides | 2006 |
Progressive multifocal leukoencephalopathy: serial high-b-value diffusion-weighted MR imaging and apparent diffusion coefficient measurements to assess response to highly active antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Brain; Diffusion; Diffusion Magnetic Resonance Imaging; HIV Protease Inhibitors; Humans; Leukoencephalopathy, Progressive Multifocal; Lopinavir; Male; Organophosphonates; Pyrimidinones; Ritonavir; Tenofovir; Zidovudine | 2007 |
Improving access to second-line antiretrovirals.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Industry; Global Health; HIV Protease Inhibitors; Humans; Lopinavir; Pyrimidinones; Ritonavir | 2007 |
Thyrotoxic periodic paralysis in a Polynesian male following highly active antiretroviral therapy for HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiretroviral Therapy, Highly Active; Autoimmunity; Diarrhea; Drug Combinations; Genetic Predisposition to Disease; Graves Disease; Hawaii; Humans; Hypokalemic Periodic Paralysis; Iodine Radioisotopes; Lamivudine; Lopinavir; Male; Native Hawaiian or Other Pacific Islander; Polynesia; Pyrimidinones; Thyrotoxicosis; Zidovudine | 2007 |
Factors associated with clinical, immunological and virological responses in protease-inhibitor-experienced Brazilian children receiving highly active antiretroviral therapy containing lopinavir-ritonavir.
Topics: Acquired Immunodeficiency Syndrome; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Child; Child, Preschool; Follow-Up Studies; HIV Protease Inhibitors; Humans; Longitudinal Studies; Lopinavir; Pyrimidinones; Ritonavir; RNA, Viral; Treatment Outcome; Viral Load | 2007 |
Improved interpretation of genotypic changes in the HIV-1 reverse transcriptase coding region that determine the virological response to didanosine.
Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Didanosine; Female; Genotype; HIV Reverse Transcriptase; HIV-1; Humans; Lopinavir; Male; Middle Aged; Mutation; Nelfinavir; Nevirapine; Pyrimidinones; Reverse Transcriptase Inhibitors; RNA, Viral; Salvage Therapy | 2007 |
Mild clinical toxicity and dose-dependent pharmacokinetics following acute lopinavir/ritonavir poisoning in a HIV-positive patient.
Topics: Acquired Immunodeficiency Syndrome; Anticoagulants; Drug Overdose; HIV Protease Inhibitors; Humans; Lopinavir; Male; Middle Aged; Pyrimidinones; Ritonavir; Warfarin | 2008 |
[Protease inhibitor Kaletra (Lopinavir/Ritonavir): significance and role in antiretroviral therapy of HIV infection and AIDS].
Topics: Acquired Immunodeficiency Syndrome; Drug Combinations; Drug Resistance, Viral; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Pyrimidinones; Ritonavir | 2007 |
Abbott AIDS medicine gets FDA approval earlier than expected.
Topics: Acquired Immunodeficiency Syndrome; Drug Combinations; HIV Protease Inhibitors; Humans; Lopinavir; Pyrimidinones; Ritonavir; United States; United States Food and Drug Administration | 2000 |
Moving forward: a treatment overview from the 12th World AIDS Conference.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Benzoxazines; Carbamates; CD4-Positive T-Lymphocytes; Clinical Trials as Topic; Congresses as Topic; Cyclopropanes; Dideoxynucleosides; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Furans; Health Services Accessibility; HIV Protease Inhibitors; Humans; Hydroxyurea; Lopinavir; Oxazines; Patient Care Planning; Pyrimidinones; Remission Induction; Reverse Transcriptase Inhibitors; Sulfonamides; Switzerland; Virus Replication | 1998 |
[After 3 years no resistance development. Protease inhibitor with staying power].
Topics: Acquired Immunodeficiency Syndrome; Clinical Trials as Topic; Drug Resistance, Viral; Drug Therapy, Combination; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; Humans; Lopinavir; Pyrimidinones; Ritonavir | 2002 |